Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 33

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 33
---
 001-14895
     
    10.8
     
    9/19/22

     10.26
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC.
     
    8-K
     
    001-14895
     
    10.9
     
    9/19/22

     10.27
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Mizuho Markets Americas LLC.
     
    8-K
     
    001-14895
     
    10.10
     
    9/19/22

     10.28
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Morgan Stanley & Co. LLC.
     
    8-K
     
    001-14895
     
    10.11
     
    9/19/22

     10.29
     
    Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and RBC Capital markets, LLC.
     
    8-K
     
    001-14895
     
    10.12
     
    9/19/22

     10.30†
     
    Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    8/8/18

     10.31†
     
    Letter Agreement between Douglas S. Ingram and Sarepta Therapeutics, Inc. dated June 26, 2018
     
    10-Q
     
    001-14895
     
    10.4
     
    8/8/18

     10.32†
     
    Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan
     
    10-Q
     
    001-14895